Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Lack of Clinical Justification for Psychotropic Medication Increase

Chicago, Illinois Survey Completed on 06-12-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to provide clinical rationale or physician documentation justifying the increase in dosage of a psychotropic medication for a resident diagnosed with multiple psychiatric conditions, including depression, schizoaffective disorder/bipolar type, major depressive disorder, alcoholism-dependence/withdrawal, and anxiety disorder. The resident was cognitively intact, as indicated by a BIMS score of 15. The physician order sheet documented an increase in Venlafaxine HCL ER from 225 mg to 300 mg daily, but there was no corresponding progress note or documentation from the interdisciplinary team (IDT) or physician explaining the need for this dosage increase or describing any behavioral interventions considered prior to the change. Review of the medication administration records confirmed that the resident received the increased dosage as ordered. The Director of Nursing (DON) was unable to provide documentation of an IDT meeting or clinical justification for the medication change. The facility's policy requires that psychotropic drug use be based on comprehensive assessment and that gradual dose reductions and behavioral interventions be implemented unless contraindicated, with dosage reductions attempted per CMS guidelines unless clinically contraindicated. These requirements were not met in this instance.

An unhandled error has occurred. Reload 🗙